On November 25, 2020, the U.S. Departments of Health & Human Services (HHS) and Treasury released the proposed 2022 “Notice of Benefit & Payment Parameters” (NBPP), the annual rule governing core provisions of the Affordable Care Act (ACA), including the operation of the marketplaces, standards for insurers, and the risk adjustment program. This expert perspective focuses on several provisions that have implications for state oversight of insurance markets and the state-based marketplaces. Comments on the proposed rule are due by December 30, 2020.
Leveraging CHIP to Protect Low-Income Children from Lead
Cindy Mann, Kinda Serafi, and Arielle Traub, Manatt Health
Despite improvements that have been made over the past several decades, lead poisoning remains a serious hazard for many children in the U.S., presenting significant risks to their health and learning. More than 4 million families with children live in homes with high levels of lead, and approximately half a million under the age of five require treatment. The Children’s Health Insurance Program (CHIP) can provide critical financial support to states as they seek to implement cost-effective lead abatement activities to protect children. This issue brief, developed by Manatt Health, describes the CHIP State Plan option, which does not require a waiver, and the opportunity it provides for states to make significant tangible reductions in lead exposure and improvements to children’s health. The brief includes specific examples in case studies from Michigan and Maryland.